NCT02640742 Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting Status COMPLETED Phase N/A
NCT02637037 A Study to Assess the Bioequivalence of Dapagliflozin/Metformin XR Fixed-dose Combination Tablets in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02635386 EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS) Status COMPLETED Phase PHASE3
NCT02632526 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02628132 Study of Safety and Efficacy of Durvalumab in Combination With Paclitaxel in Metastatic Triple Negative Breast Cancer Patients Status COMPLETED Phase PHASE1/PHASE2
NCT02624973 PErsonalized TREatment of High-risk MAmmary Cancer - the PETREMAC Trial Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02622581 Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients Status RECRUITING Phase N/A
NCT02619864 mTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme Status COMPLETED Phase PHASE1
NCT02617290 Assessment of Loading With the P2Y12 Inhibitor Ticagrelor or Clopidogrel to Halt Ischemic Events in Patients Undergoing Elective Coronary Stenting Status COMPLETED Phase PHASE3
NCT02617277 Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours Status COMPLETED Phase PHASE1
NCT02616666 A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients Status COMPLETED Phase PHASE4
NCT02612662 A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02610075 Phase Ib Study to Determine MTD of AZD1775 Monotherapy in Patients With Locally Advanced or Metastatic Solid Tumours. Status COMPLETED Phase PHASE1
NCT02606851 Proton Pump Inhibitor Empirical Treatment in Management of Outpatients With Gastroesophageal Reflux Disease. Status COMPLETED Phase N/A
NCT02605616 Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD) Status TERMINATED Phase PHASE2